H.C. Wainwright Reiterates Buy Rating on Akari Therapeutics (AKTX)

Go back to H.C. Wainwright Reiterates Buy Rating on Akari Therapeutics (AKTX)
(NASDAQ: AKTX) Delayed: 14.99 +0.36 (2.46%)
Previous Close $14.63    52 Week High $19.75 
Open $14.19    52 Week Low $7.63 
Day High $16.05    P/E N/A 
Day Low $13.05    EPS $0.00 
Volume 59,650